Clinical Trials

20 enrolled

Sarcoma

NCT06214793 2026-06-05

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

61 enrolled

Breast Neoplasms

NCT06630221 2026-06-05

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

MyeloidOther hematologic neoplasm

25 enrolled

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT07071961 2026-06-05

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

16 enrolled

Colorectal Neoplasms

NCT04519879 2026-06-03

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

133 enrolled

Prostatic Neoplasms

NCT04803201 2026-06-02

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

170 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT05751668 2026-06-02

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

98 enrolled

Breast Neoplasms

NCT06405061 2026-05-29

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

40 enrolled

Carcinoma, Hepatocellular

NCT05198479 2026-05-22

SG-AAA-II-01

25 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT05475171 2026-05-22

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

47 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT06955169 2026-05-22

MOMENTUM-1

153 enrolled

Meningioma

NCT03722680 2026-05-20

RILUZOX-01

80 enrolled

Colorectal Neoplasms

NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

LymphoidOther hematologic neoplasm

80 enrolled

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

EndocrineGynecologicLymphoidOther solid neoplasmThoracic

140 enrolled

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT06348147 2026-05-04

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

39 enrolled

Plasma cell

Multiple Myeloma

NCT05955261 2026-04-23

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Other hematologic neoplasm

70 enrolled

Leukemia, Myeloid, Acute

NCT06894225 2026-04-20

Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

12 enrolled

Glioblastoma

NCT03575611 2026-04-15

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

123 enrolled

Carcinoma, Renal Cell

NCT03164460 2026-03-20

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

68 enrolled

Recurrent Head and Neck Carcinoma

NCT07011550 2026-03-20

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

7 enrolled

Microsatellite-stable Colorectal Cancer

NCT05797870 2026-03-19

Lip-Re2

16 enrolled

Hepatocellular Carcinoma Non-resectable

NCT05656131 2026-03-17

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

80 enrolled

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

126 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06860386 2026-03-06

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

75 enrolled

Carcinoma, Renal Cell

NCT05928806 2026-02-11

ARCITECT

120 enrolled

Advanced Renal Cell Carcinoma

NCT03316573 2026-02-10

Pembrolizumab in Neoplasms or Lymphomas

18 enrolled 16 charts

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

NCT04661137 2026-02-10

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

96 enrolled

Plasma cell

Multiple Myeloma

NCT03875144 2026-02-09

MESOTIP

66 enrolled

Gynecologic

Peritoneal Neoplasms

NCT05062889 2026-02-03

ERASE-CRC

477 enrolled

Colonic Neoplasms

NCT06254911 2026-01-27

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

20 enrolled

Oropharyngeal Neoplasms

NCT06575686 2026-01-21

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

33 enrolled

Lymphoid

Lymphoma, Follicular

NCT05183204 2025-12-18

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

33 enrolled

Glioblastoma

NCT05358704 2025-12-04

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

38 enrolled

Rectal Neoplasms

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

10 enrolled

Glioma

NCT05445609 2025-09-19

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

10 enrolled

Prostatic Neoplasms

NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

1 enrolled

Diffuse Intrinsic Pontine Glioma

NCT05591534 2025-08-01

ICUREC

31 enrolled

Rectal Neoplasms

NCT06728657 2025-06-18

TORCH-G

68 enrolled

Stomach Adenocarcinoma

NCT05375708 2025-03-28

SIRIUS

93 enrolled

Colorectal Neoplasms

NCT04840186 2024-11-12

EXCALIBUR3

62 enrolled

Colorectal Neoplasms

NCT06199882 2024-10-15

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

34 enrolled

Biliary Tract Carcinoma

NCT04824352 2024-05-14

AIEO

44 enrolled

Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04090463 2024-05-07

PancFORT

100 enrolled

Pancreatic Neoplasms

NCT04668768 2024-03-22

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

3 enrolled

Lymphoid

Lymphoma

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

6 enrolled

Dermatologic

Melanoma

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

170 enrolled

Breast Neoplasms

NCT03139747 2021-10-15

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

5 enrolled

Thyroid Neoplasms

NCT04084158 2021-02-23

A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

100 enrolled

Esophageal Squamous Cell Carcinoma

NCT00738777 2021-01-22

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

250 enrolled

Breast Neoplasms

NCT01988831 2019-05-10

Efficacy of Propranolol Treatment to Prevent Melanoma Progression